Enhanced Group (ENHA) Investor update summary

Business model and strategy

• Enhanced operates two main businesses: the Enhanced Games, which allows athletes to use FDA-approved performance enhancements under medical supervision, and the Live Enhanced consumer platform, offering both OTC supplements and prescription therapies for longevity and performance.

• The consumer platform leverages learnings from elite athletes to personalize protocols for the general public, aiming to capture a significant share of the $85 billion U.S. peptide market.

• The business flywheel is driven by the synergy between sports and consumer health, using athlete data and protocols to inform and differentiate consumer offerings.

• Enhanced prioritizes product quality, transparency, and affordability, with a focus on evidence-based, personalized health solutions.

• The company aims to build a trusted brand through scientific rigor, medical oversight, and educational content, positioning itself as a leader in performance medicine.

Enhanced Games and athlete program

• The Enhanced Games disrupt traditional sports by allowing medically supervised enhancements and offering equitable, substantial athlete compensation.

• Athlete protocols are individualized, with significant investment in health monitoring, coaching, nutrition, and mental support.

• The games serve as a content engine, with a focus on digital distribution and creator partnerships to maximize reach and engagement.

• Sponsorships are aligned with the brand's disruptive mission, and operational synergies are leveraged with partners in content, AI, and streaming.

• The long-term vision is to create a sustainable, cash-flow-positive sports business that elevates athlete performance and public awareness of safe enhancement.

Consumer platform and personalization

• The Live Enhanced platform offers both OTC and prescription products, with a commitment to full ingredient transparency and superior formulation.

• Personalization is central, with ongoing development of individualized supplement and hormone protocols informed by clinical data from elite athletes.

• The platform targets proactive, health-conscious consumers, aiming to make enhancements accessible and affordable beyond elite clinics.

• Regulatory changes, such as FDA reclassification of peptides, are expected to expand the product offering and market reach.

• The company emphasizes continuous improvement of protocols through data, medical oversight, and consumer feedback, aiming to set industry standards.